Stories | Patient Daily

Regulatory

Press release submission | Jul 3, 2022

Innovent Announces First Patient Dosed in a Phase 2 Clinical study of IBI112 (IL-23p19 Monoclonal Antibody) in Patients with Moderate-to-Severe Active Ulcerative Colitis

Press release submission | Jul 1, 2022

More Surgical Care Cuts Take Effect Today, Harming Patients

Press release submission | Jul 1, 2022

FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for subgroup of Patients with Critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir

Press release submission | Jun 30, 2022

Big Win for Patients: Aetna Drops Prior Authorization for Most Cataract Surgeries

+ Technology/Innovation

Press release submission | Jun 29, 2022

New Study: Oxaloacetate Reduces Chronic Fatigue In Just Six Weeks, Promising Data for ME/CFS Patients

+ Technology/Innovation

Press release submission | Jun 24, 2022

BioFluidica Next-Generation Liquid Biopsy Platform Uncovers Undiagnosed HER2+ Patients

Press release submission | Jun 24, 2022

OM1 Launches a New Estimation Model for the Expanded Disability Status Score (EDSS) for Multiple Sclerosis Patients

Press release submission | Jun 23, 2022

CHMP issues a positive opinion recommending full approval of Oncopeptides Pepaxti in EU for patients with triple class refractory multiple myeloma

Trending

+ Pharmaceuticals

Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals

Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation